Risk-based screening, early symptom recognition, and patient engagement can help pharmacists detect chronic kidney disease and prevent progression.
Keith Bellovich, DO
Advertisement
Articles by Keith Bellovich, DO
Keith Bellovich, DO, explains how SARS-CoV-2–driven inflammation contributes to kidney injury and may reveal previously undiagnosed chronic kidney disease.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Peptide Compounding Is Evolving: What Pharmacists Need to Know Now
2
Dostarlimab Receives FDA Accelerated Approval for MSI-H/dMMR Locally Advanced Rectal Cancer
3
Finerenone in Heart Failure: Evidence and Practice a Year Later
4
FDA Approves Phentolamine Eye Drop for Presbyopia in Adults
5